RG

Rajnikant Gandalal Vyas

Active Director Director DIN 00837447
DIN 00837447 First appointment May 1995 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 18 historical roles
Total affiliations 24 Since May 1995
Shareholding value •••• Premium profile

About Rajnikant Gandalal Vyas

Data last updated:

Rajnikant Gandalal Vyas is a Director at Meril Diagnostics Private Limited (since 2011), Whole-Time Director at Meril Endo Surgery Private Limited (since 2011) and Director at Mitsu Energy Private Limited (since 2007), and holds 3 more current directorships. The companies operate in Healthcare, Energy and Power and Trading. The 4 current companies with reported revenue have a combined latest revenue of ₹813 Cr; the largest is Meril Diagnostics Private Limited at ₹444 Cr (FY 2025). Earlier, Rajnikant Gandalal Vyas was a Director at Micro Life Sciences Private Limited (2009–2021) and Director at Meril Healthcare Private Limited (2014–2020) and 16 more.

DIN 00837447
Primary Designation Director
Industry Healthcare
First Appointment 03 May 1995
Oldest Company Age 35 yrs
Largest company Meril Diagnostics Private Limited · ₹444 Cr (FY 2025)
Combined revenue ₹813 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meril Diagnostics Private Limited U33110GJ2011PTC064994
Director18 Apr 20112011₹444 Cr (FY 2025)Active
Meril Endo Surgery Private Limited U33110GJ2011PTC065366
Whole-Time Director10 May 20112011₹368 Cr (FY 2025)Active
Mitsu Energy Private Limited U70100GJ2006PTC049225
Director09 Jan 20072006₹1.09 Cr (FY 2025)Active
Mexus Technology Private Limited U51909GJ1991PTC015340
Director17 Apr 20211991₹9.3 Lakh (FY 2017)Active
Meril Coreglobal Private Limited U82990GJ2026PTC178992
Non- Individual Subscriber11 Jun 20262026Active
Mapel Infrastructure Private Limited U45400MH2008PTC180804
Director27 Mar 20092008Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Micro Life Sciences Private Limited U24119GJ2006PTC048361
Director29 Sep 20092006₹4,992 Cr (FY 2025)Active
Meril Healthcare Private Limited U24230GJ2011PTC065022
Director20 Sep 20142011₹1,412 Cr (FY 2025)Active
Meril Life Sciences Private Limited U24239GJ2007PTC051137
Additional Director14 Sep 20072007₹1,730 Cr (FY 2025)Active
M Graph Industries Private Limited U36900GJ2007PTC083489
Additional Director20 Feb 20082007Active
Ensemble Interiors Private Limited U72900MH2007PTC172081
Director02 Jul 20072007₹4,488 (FY 2023)Active
Director10 May 20112011Strike Off
Meril Orthopedic Private Limited U24232GJ2008PTC052865
Director03 Oct 20112008Strike Off
Director09 Dec 20092009Strike Off
Meril Medical Private Limited U33110GJ2011PTC064993
Director18 Apr 20112011₹4,300 (FY 2018)Strike Off
Meril Therapeutics Private Limited U33110GJ2011PTC065364
Director10 May 20112011Strike Off
Meril Ophthalmic Private Limited U33110GJ2011PTC066547
Director27 Jul 20112011Strike Off
Meril Dental Private Limited U33110GJ2011PTC068200
Director14 Dec 20112011Strike Off
Meril Ent Private Limited U33110GJ2011PTC068202
Director14 Dec 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meril Pharmaceuticals Private Limited
Meril Orthopedic Private Limited
Interventional Technologies & Devices Pr Ivate Limited
Meril Medical Private Limited
Premium access

Shareholding and investment profile for Rajnikant Gandalal Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajnikant Gandalal Vyas

Rajnikant Gandalal Vyas currently holds 6 directorships: Meril Diagnostics Private Limited (Director, since 18 Apr 2011, revenue ₹444 Cr (FY 2025)); Meril Endo Surgery Private Limited (Whole-Time Director, since 10 May 2011, revenue ₹368 Cr (FY 2025)); Mitsu Energy Private Limited (Director, since 09 Jan 2007, revenue ₹1.09 Cr (FY 2025)); Mexus Technology Private Limited (Director, since 17 Apr 2021, revenue ₹9.3 Lakh (FY 2017)); Meril Coreglobal Private Limited (Non- Individual Subscriber, since 11 Jun 2026); and 1 more.

Rajnikant Gandalal Vyas was first appointed on 03 May 1995 as Director at Greymatter Consultants Private Limited. The most recent appointment on record is 11 Jun 2026 at Meril Coreglobal Private Limited.

The 4 current companies of Rajnikant Gandalal Vyas that report revenue have a combined latest revenue of ₹813 Cr: Meril Diagnostics Private Limited ₹444 Cr (FY 2025); Meril Endo Surgery Private Limited ₹368 Cr (FY 2025); Mitsu Energy Private Limited ₹1.09 Cr (FY 2025); Mexus Technology Private Limited ₹9.3 Lakh (FY 2017).

Rajnikant Gandalal Vyas held 18 earlier board appointments: Micro Life Sciences Private Limited (Director, 29 Sep 2009 to 15 May 2021); Meril Healthcare Private Limited (Director, 20 Sep 2014 to 16 Feb 2020); Meril Life Sciences Private Limited (Additional Director, 14 Sep 2007 to 25 Jan 2008); M Graph Industries Private Limited (Additional Director, 20 Feb 2008 to 22 Sep 2008); Ensemble Interiors Private Limited (Director, 02 Jul 2007 to 30 Jun 2014); and 13 more.

The current boards of Rajnikant Gandalal Vyas's companies include Pramodkumar Minocha (Meril Diagnostics Private Limited), Vishakha Kiran Sonaje (Meril Diagnostics Private Limited), Alpesh Mansukhlal Chaniyara (Meril Endo Surgery Private Limited), Hemchandra Yadunandan Panjikar (Meril Endo Surgery Private Limited), Sanjay Prafullabhai Shah (Mitsu Energy Private Limited), Nanubhai Premjibhai Bambharolia (Meril Coreglobal Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available